ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SYSTEM SCLEROSIS PULMONARY AVEOLITIS

口服环磷酰胺与口服安慰剂治疗系统性硬化性肺泡炎

• 批准号: 7608280
• 负责人: VIRGINIA D STEEN
• 金额: $ 0.13万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7608280
• 关键词: Anti-Inflammatory Agents; Anti-inflammatory; Computer Retrieval of Information on Scientific Projects Database; Cyclophosphamide; Dose; Funding; Grant; Immunosuppressive Agents; Institution; Kilogram; Lung; Names; Oral; Patients; Pharmaceutical Preparations; Placebos; Reporting; Research; Research Personnel; Resources; Respiratory physiology; Scleroderma; Sclerosis; Source; System; Tablets; Toxic effect; United States National Institutes of Health; day; design; improved; milligram; prevent

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study has been designed to evaluate whether cyclophosphamide (a strong anti-inflammatory and immunosuppressant medication, trade named Cytoxan) is better than placebo (an inert, no effective treatment) in preventing lung damage from scleroderma from getting worse. This rail will compare 2 milligrams per kilogram per day of cyclophosphamide (approximately 100-150 mg in tablet form) with a placebo that looks like cyclophosphamide but is inert, with allowances for dose adjustments for toxicity. In previous studies from several centers, improvement in lung function was reported to have occurred after starting cyclophosphamide. In one recent study, lung function improved by greater than 10% in 3/4 of the cyclophosphamide patients and in 1/4 of the non-treated patients. This study is designed toexamine in a scientific fashion whether cyclophosphamide does actually improve lung function in people with scleroderma with early lung involvement.

这个子项目是众多研究子项目之一